Your browser doesn't support javascript.
loading
The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses.
Bohler, Robert M; Freeman, Patricia R; Villani, Jennifer; Hunt, Tim; Linas, Beth S; Walley, Alexander Y; Green, Traci C; Lofwall, Michelle R; Bridden, Carly; Frazier, Lisa A; Fanucchi, Laura C; Talbert, Jeffery C; Chandler, Redonna.
Affiliation
  • Bohler RM; Institute for Behavioral Health, Brandeis University, 415 South Street, Waltham, MA 02453, United States.
  • Freeman PR; Department of Pharmacy Practice and Science, University of Kentucky, Lexington, KY, United States.
  • Villani J; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.
  • Hunt T; School of Social Work, Social Intervention Group (SIG), Center for Healing of Opioid and Other Substance Use Disorders (CHOSEN), Columbia University, New York, NY, United States.
  • Linas BS; RTI International, Research Triangle Park, NC, United States.
  • Walley AY; Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, United States.
  • Green TC; Institute for Behavioral Health, Brandeis University, 415 South Street, Waltham, MA 02453, United States.
  • Lofwall MR; Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, United States.
  • Bridden C; Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, United States.
  • Frazier LA; Center for Health Outcomes and Policy Evaluation Studies, College of Public Health, The Ohio State University, Columbus, OH, United States.
  • Fanucchi LC; Department of Internal Medicine, Division of Infectious Disease, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, United States.
  • Talbert JC; Institute for Biomedical Informatics, University of Kentucky College of Medicine, Lexington, KY, United States.
  • Chandler R; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.
Article in En | MEDLINE | ID: mdl-36643788
ABSTRACT

Background:

Expanding access to naloxone is one of the most impactful interventions in decreasing opioid-related mortality. However, state distribution rates of naloxone are insufficient to meet community need. The current study sought to better understand this gap by focusing on state policies that may facilitate or impede naloxone distribution in four states highly impacted by fatal opioid overdoses - Kentucky, Massachusetts, New York, and Ohio.

Methods:

We provide a descriptive analysis of the policy landscape impacting naloxone distribution through pharmacy and community channels in the four states participating in the HEALing Communities Study (HCS). Publicly available data and the expertise of the research team were used to describe each state's naloxone access laws (NALs), Medicaid coverage of naloxone, and community overdose education and naloxone distribution infrastructure. Data presented in this study represent the most current policy landscape through September 2022.

Results:

Variation exists between specific components of the NALs of each state, the structure of Medicaid coverage of naloxone, and the community distribution infrastructure networks. Massachusetts and New York have a statewide standing order, but other states use different strategies short of a statewide standing order to expand access to naloxone. Quantity limits specific to naloxone may limit access to Medicaid beneficiaries in some states.

Conclusion:

States participating in the HCS have developed innovative but different mechanisms to ensure naloxone access. Policies were dynamic and moved towards greater access. Research should consider the policy landscape in the implementation and sustainability of interventions as well as the analysis of outcomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Drug Alcohol Depend Rep Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Drug Alcohol Depend Rep Year: 2023 Document type: Article Affiliation country: United States